Medical/Pharmaceuticals
Adagene Establishes Collaboration for Clinical Trial of ADG106 in Combination with Nivolumab in Patients with Non-Small Cell Lung Cancer in Singapore
- Phase 1b/2 trial to be conducted at the National University Cancer Institute, Singapore and the National Cancer Centre Singapore, in Collaboration with the Singapore Translational Cancer Consortium - - ADG106 now being evaluated in combinations with three leading anti-PD-1 therapies - SAN DIEG...
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), in a Two Drug Regimen, Proves Safe and Effective for Critically Ill Hospitalized AIDS Patients
LONDON, Oct. 27, 2021 /PRNewswire/ -- Frontier Biotechnologies today shared real-world evidence of Albuvirtide (ABT)-based two drug regimen's safety and efficacy for hospitalized AIDS patients at the European AIDS Clinical Society (EACS) Conference. Observations from a single-center, retrospec...
Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom
* Filing marks first protein-based COVID-19 vaccine submitted to MHRA for authorization * All modules required for regulatory review, including CMC data, are now complete * Submission based on Phase 3 data from ~45K patients demonstrating high efficacy and well-tolerated safety, including a...
European Wellness Collaborates with Heidelberg University Germany to Conduct Efficacy Studies of Peptides and Cell Therapy Research
FRANKFURT, Germany, Oct. 27, 2021 /PRNewswire/ – European Wellness Academy (EWA), the educational arm of European Wellness Biomedical Group (EWG), has signed an agreement to carry out joint scientific research on theefficacy of peptides, cell therapy, exosomes and cell reprogramming for rejuvenat...
Launch of #SGUnited COVID-19 Assistance Telemedicine Initiative by UNO Tech
SINGAPORE, Oct. 27, 2021 /PRNewswire/ -- Singapore has seen a sharp increase in
daily COVID-19 cases since September, reaching an approximate average of 3,000
daily cases. Primary Care avenues such as General Practitioners and
Telemedicine service providers are stretched thin.
HT Supreme® Drug Eluting Stent performs equivalent to best-in-class in the PIONEER III publication
TIANJIN, China, Oct. 27, 2021 /PRNewswire/ -- SINOMED, a leading international medical device company, announced that the clinical trial results for its HT Supreme® Drug-Eluting Stent (DES) System has been published in Circulation. The article described results from the PIONEER III trial where i...
Haier's HCH Ventures Partners with RF Imaging Leader Vayyar to Establish Joint Venture in China
The Joint Venture partnership will initially focus on providing touchless fall detection for seniors as well as expanding Vayyar's activities in the Chinese market - HCH, a subsidiary of Haier, signs Joint Venture agreement with Israeli technology provider, Vayyar, aiming to address the4 trillio...
Medigen's MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines
TAIPEI, Oct. 27, 2021 /PRNewswire/ -- Medigen Vaccine Biologics Corp (MVC)
Elekta receives initial investment grade rating from S&P Global Ratings
STOCKHOLM, Oct. 26, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has received an investment grade (IG) rating from S&P Global Ratings (S&P). S&P has assigned a BBB- rating to Elekta and to the Group's senior unsecured notes, with stable outlook. S&P notes that Elekta's rating r...
Introducing Prodigy for Improved Peptide Purification
-- Improved resolution and separation of peptide impurities -- Easier purification of hydrophobic peptides -- Direct transfer from analytical to preparative scale MATTHEWS, N.C., Oct. 26, 2021 /PRNewswire/ -- CEM Corporation is proud to announce the release of the new Prodigy™ Preparative High-P...
Medigate Launches Clinical Device Efficiency to Improve Operational Efficiency for HDOs
The new offering from the medical device cybersecurity leader aims to increase medical device visibility, streamline hospital workflows, and reduce costs BROOKLYN, N.Y., Oct. 26, 2021 /PRNewswire/ -- Medigate, creator of the industry's first and leading healthcare-specific platform to orchestrate...
Qilian International Holding Group Limited Completes Phase One of Its Expansion of New Organic Fertilizer Production Facility and Puts It into Production
JIUQUAN, China, Oct. 26, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), aChina-based pharmaceutical and chemical products manufacturer, today announced that the Company has completed phase one of the expansion of its new organic fertilizer produc...
I-Mab Announces Strategic Partnership with Sinopharm in Preparation for Launch of its Innovative Assets in China
* I-Mab strategic partnership with Sinopharm will covers all aspects of the go-to-market process, including authorization of more than 300 Sinopharm's subsidiaries as distributors acrossChina. * I-Mab is on track to submit BLA for third line multiple myeloma (MM) treatment by Q4 2021. * The...
Samsung Biologics Reports Third Quarter 2021 Financial Results
* Q3'21 revenue of KRW 450.7 billion increased 64% compared to Q3'20. * Q3'21 operating profit of KRW 167.4 billion increased 196% compared to Q3'20. * Stable supply, strong operational excellence and a high utilization rate across all plants. * Active investment on expansion, pre-sales ac...
Finalist teams for "2021 Asia Super Team:Future Land" are here
TAIPEI, Oct. 26, 2021 /PRNewswire/ -- Here comes "2021 Asia Super Team" again! It is the eighth consecutive year that the Taiwanese government holds the "Asia Super Team" competition. This year, the competition is centered around a new theme - Future Land - inviting enterprises fromJapan, Vietnam...
Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818
JIAXING, China and BURLINGAME, Calif., Oct. 25, 2021 /PRNewswire/ -- Angel Pharmaceuticals Co., Ltd. ("Angel Pharma") today announced that its IND application for CPI-818, a small molecule ITK inhibitor, has been approved by the Center for Drug Evaluation (CDE) to initiate clinical trials in pati...
SCN9A Antisense Pain Killer OLP-1002 Moves into Phase 2a Stage
SEOUL, South Korea, Oct. 25, 2021 /PRNewswire/ -- OliPass Corporation, a South Korea based biotech specialized in the development of RNA therapeutics, announced to initiate a Phase 2a trial for SCN9A antisense pain killer OLP-1002 inAustralia. In the Phase 2a trial of a two stage adaptive design ...
Antengene to Host its First R&D Days on November 16 and November 18, 2021
* Virtual Event (in English) on November 16 * On Site Event with Live Webcast (in Mandarin) on Nov 18 SHANGHAI and HONG KONG, Oct. 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, deve...
111, Inc. Announces Strategic Partnership with Chugai Pharma China Co., Ltd. to Accelerate Innovations in Chronic Disease Management
SHANGHAI, Oct. 25, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced a strategic cooperation agreement with Chugai Phar...
Hummingbird Bioscience to Collaborate with Merck on Clinical Trial of Anti-VISTA Antibody HMBD-002 in Combination with KEYTRUDA® (Pembrolizumab) for Treatment of Cancer
HOUSTON and SINGAPORE, Oct. 25, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to improve treatment outcomes, today announced it has entered into a clinical trial collaboration agreem...
Week's Top Stories
Most Reposted
Mastercard elevates premium travel with Asia Pacific's first Taste by Priceless dining club at Hong Kong International Airport
[Picked up by 322 media titles]
2026-08-05 11:34Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
[Picked up by 311 media titles]
2026-07-30 10:45J.P. Morgan Private Bank Earns Record 10 Accolades at The Asset Triple A Private Capital Awards 2026
[Picked up by 296 media titles]
2026-07-30 15:00Hyatt Regency Kuala Lumpur At KL Midtown: A Refined Urban Retreat Recognised For Design Excellence
[Picked up by 295 media titles]
2026-08-04 07:00